Abstract DP198: Association of Systemic Immune-Inflammation Index With Hemorrhagic Transformation Following Endovascular Therapy for Ischemic Stroke

Introduction: The Systemic Immune-Inflammation Index (SII) is an inflammation–immunity marker that has recently attracted increasing attention in vascular diseases. We investigated the association between SII and hemorrhagic transformation in patients with acute ischemic stroke who underwent endovascular therapy (EVT). As secondary analyses, we examined relationships with the stress hyperglycemia ratio (SHR), a sensitive marker of acute stress response and sympathetic activation, early neurological deterioration (END), and clinical outcomes. Methods: We screened consecutive ischemic stroke patients considered eligible for EVT between May 2014 and May 2025. Inclusion criteria were: (1) availability of admission SII, calculated as platelets × neutrophils / lymphocytes (10 3 /µL); and (2) assessment of symptomatic intracerebral hemorrhage (ICH) after EVT, defined as an NIHSS score worsening ≥4. Patients achieving spontaneous recanalization on initial angiography were excluded. SHR was defined as admission glucose [mg/dL] / (28.7 × HbA1c [%] – 46.7). END was defined as neurological worsening of NIHSS ≥2 within 72 hours after admission. Unfavorable outcome was defined as mRS score 4–6 at 3 months. Results: Of 336 screened patients, 317 (161 men; median age, 80 years) were included. Symptomatic ICH was observed in 30 patients (9%). Higher SII was significantly associated with symptomatic ICH across all multivariable models ( p <0.005, Figure 1). Higher SII was also associated with European Cooperative Acute Stroke Study (ECASS)-defined parenchymal hematoma type 2 at 24 hours after EVT, as well as with ICH ≥ECASS parenchymal hematoma type 1 ( p <0.005, Figure 1). In addition, SII positively correlated with SHR (B 1090, 95% CI 636.6~1544, p <0.001, Figure 2). Finally, SII was independently associated with END (PR 1.119, 95% CI 1.002~1.249, p =0.045, Figure 3A) and unfavorable outcome (PR 1.119, 95% CI 1.029~1.217, p =0.009, Figure 3B). Conclusions: Elevated SII reflects acute stress response and sympathetic activation in ischemic stroke patients undergoing EVT and may serve as a predictor of hemorrhagic complications and unfavorable outcomes.

Authors

Institutions

Publication Details

Journal
Stroke
Published
2026-01-29
DOI
https://doi.org/10.1161/str.57.suppl_1.dp198
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract DP198: Association of Systemic Immune-Inflammation Index With Hemorrhagic Transformation Following Endovascular Therapy for Ischemic Stroke

Yujiro Higuchi, Go Takaguchi, Kyosuke Hamada, Takeo Sato et al.
Stroke
Inflammatory Biomarkers in Disease Prognosis
article

Abstract DP198: Association of Systemic Immune-Inflammation Index With Hemorrhagic Transformation Following Endovascular Therapy for Ischemic Stroke

Yujiro Higuchi, Go Takaguchi, Kyosuke Hamada, Takeo Sato, Kana Iwamoto, Mei Ikeda, Yutaro Kawabata, Hiroshi Takashima, Yuki Hamada, Takumi Shimada, Hideki Matsuoka
article en

Abstract

Introduction: The Systemic Immune-Inflammation Index (SII) is an inflammation–immunity marker that has recently attracted increasing attention in vascular diseases. We investigated the association between SII and hemorrhagic transformation in patients with acute ischemic stroke who underwent endovascular therapy (EVT). As secondary analyses, we examined relationships with the stress hyperglycemia ratio (SHR), a sensitive marker of acute stress response and sympathetic activation, early neurological deterioration (END), and clinical outcomes. Methods: We screened consecutive ischemic stroke patients considered eligible for EVT between May 2014 and May 2025. Inclusion criteria were: (1) availability of admission SII, calculated as platelets × neutrophils / lymphocytes (10 3 /µL); and (2) assessment of symptomatic intracerebral hemorrhage (ICH) after EVT, defined as an NIHSS score worsening ≥4. Patients achieving spontaneous recanalization on initial angiography were excluded. SHR was defined as admission glucose [mg/dL] / (28.7 × HbA1c [%] – 46.7). END was defined as neurological worsening of NIHSS ≥2 within 72 hours after admission. Unfavorable outcome was defined as mRS score 4–6 at 3 months. Results: Of 336 screened patients, 317 (161 men; median age, 80 years) were included. Symptomatic ICH was observed in 30 patients (9%). Higher SII was significantly associated with symptomatic ICH across all multivariable models ( p <0.005, Figure 1). Higher SII was also associated with European Cooperative Acute Stroke Study (ECASS)-defined parenchymal hematoma type 2 at 24 hours after EVT, as well as with ICH ≥ECASS parenchymal hematoma type 1 ( p <0.005, Figure 1). In addition, SII positively correlated with SHR (B 1090, 95% CI 636.6~1544, p <0.001, Figure 2). Finally, SII was independently associated with END (PR 1.119, 95% CI 1.002~1.249, p =0.045, Figure 3A) and unfavorable outcome (PR 1.119, 95% CI 1.029~1.217, p =0.009, Figure 3B). Conclusions: Elevated SII reflects acute stress response and sympathetic activation in ischemic stroke patients undergoing EVT and may serve as a predictor of hemorrhagic complications and unfavorable outcomes.

StrokeVol. 57(Suppl_1)
Kagoshima University (JP), Kagoshima Medical Center (JP)
Openalex Percentile: Top 73%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.